Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
Product containing fenoterol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
sympatomimetikumforbindelse |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
Ipratropium bromide |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
Product containing ipratropium (medicinal product) |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
Ipratropium bromide |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
fenoterolhydrobromid |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ipratropium bromide (substance) |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Fenoterol hydrobromide (substance) |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
Fenoterol hydrobromide+ipratropium bromide |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ipratropium (substance) |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
Product containing fenoterol and ipratropium (medicinal product) |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Fenoterol (substance) |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Has manufactured dose form |
inhalationsdoseringsform |
false |
Inferred relationship |
Some |
|
|
enoterolhydrobromid 500 µg + ipratropiumbromid 1,25 mg nebulisatorampul |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|